Physician profile
Alan Y Lim
NPI 1609954346
$2,681.80
in general payments reported to CMS, 2019-2025
15 companies · $298 in 2025
The $298 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $313 · 2020: $287 · 2021: $284 · 2022: $670 · 2023: $628 · 2024: $202 · 2025: $298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,127.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,127.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mentor Worldwide LLC | $522.61 | 2019-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $331.85 | 2022-2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Musculoskeletal Transplant Foundation INC. | $271.73 | 2019-2023 | |
| Abbvie INC. | $226.34 | 2025 | |
| Integra Lifesciences Corporation | $224.77 | 2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Sientra, INC. | $200.73 | 2022 | |
| Medtronic USA, INC. | $185.47 | 2020 | |
| Baudax Bio INC. | $126.26 | 2021 | |
| Allergan, INC. | $117.55 | 2021 | |
| Avita Medical Americas, LLC | $103.98 | 2024 | |
| Davol INC. | $96.02 | 2023 | Phasix Mesh |
| Kerecis Limited | $89.44 | 2022 | |
| Stryker Corporation | $75.48 | 2020 | |
| Lifenet Health | $71.17 | 2025 | Theragenesis Wound Matrix |
| Pfizer INC. | $38.40 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Lim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.